is Novo Nordisk past its ‘peak uncertainty’?
At one point, it was Europe’s most valuable company. Now, as Danish pharmaceutical group Novo Nordisk prepares to publish its third-quarter earnings on Wednesday, the picture looks very different. Jonathan Raa | Nurphoto | Getty Images CNBC’s Charlotte Reed will travel to Copenhagen to speak with the company’s new CEO Mark Doustdar, a 30-year veteran…
